Evaluation of the Impact of Tocilizumab Use in Recipients of CAR T Cells for Non-Hodgkin Lymphoma

被引：0
|
作者：
Cassanello, Giulio [1 ,2 ]
Luttwak, Efrat [3 ]
Devlin, Sean M. [4 ]
De Abia, Alejandro Luna [1 ]
Corona, Magdalena [1 ]
Landego, Ivan [1 ]
Parascondola, Allison [1 ]
Saldia, Amethyst [1 ]
Alarcon Tomas, Ana [1 ,5 ]
Dahi, Parastoo B. [1 ]
Lin, Richard J. [1 ]
Palomba, M. Lia [3 ]
Park, Jae H. [6 ]
Salles, Gilles [3 ]
Perales, Miguel-Angel [1 ]
Scordo, Michael [1 ]
Shouval, Roni [1 ]
Shah, Gunjan L. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplant Serv, New York, NY USA
[2] Univ Milan, Milan, Italy
[3] Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, New York, NY USA
[4] Mem Sloan Kettering Canc Ctr, Dept Biostat & Epidemiol, New York, NY USA
[5] Hosp Gen Univ Gregorio Maranon, Div Hematol & Hemotherapy, Madrid, Spain
[6] Mem Sloan Kettering Canc Ctr, New York, NY USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-190500
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Impact of Preemptive Use of Tocilizumab on Chimeric Antigen Receptor T Cell Outcomes in Non-Hodgkin Lymphoma
    De Philippis, Chiara
    Mannina, Daniele
    Giordano, Laura
    Costantini, Elena
    Marcheselli, Simona
    Mariotti, Jacopo
    Sarina, Barbara
    Taurino, Daniela
    Santoro, Armando
    Bramanti, Stefania
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (07): : 429.e1 - 429.e6
  • [2] Emerging Role of CAR T Cells in Non-Hodgkin's Lymphoma
    Avanzi, Mauro P.
    Brentjens, Renier J.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (11): : 1429 - 1437
  • [3] The acceleration of CAR-T therapy in non-Hodgkin lymphoma
    Munshi, Pashna N.
    Ujjani, Chaitra
    HEMATOLOGICAL ONCOLOGY, 2019, 37 (03) : 233 - 239
  • [4] CAR-T Therapy Is Approved for Non-Hodgkin Lymphoma
    Jaklevic, Mary Chris
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (11): : 1032 - 1032
  • [5] CAR-T immunotherapy promising for non-Hodgkin lymphoma
    不详
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (11) : 2720 - 2720
  • [6] CD30-DIRECTED CAR T-CELLS FOR THE TREATMENT OF PEDIATRIC HODGKIN LYMPHOMA AND NON-HODGKIN LYMPHOMA
    Hucks, George
    Savoldo, Barbara
    Dotti, Gianpietro
    Cheng, Catherine
    Laing, Spencer
    Kasow, Kimberly
    Winstead, Michael
    Patel, Arpita
    Presler, Cammie
    Grover, Natalie
    Shea, Thomas
    Riches, Marcie
    Beaven, Anne
    Serody, Jonathan
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S12 - S13
  • [7] Prophylactic Tocilizumab Prior to Anti-CD19 CAR-T Cell Therapy for Non-Hodgkin Lymphoma
    Caimi, Paolo F.
    Pacheco Sanchez, Gabriela
    Sharma, Ashish
    Otegbeye, Folashade
    Ahmed, Nausheen
    Rojas, Patricio
    Patel, Seema
    Kleinsorge Block, Sarah
    Schiavone, Jennifer
    Zamborsky, Kayla
    Boughan, Kirsten
    Hillian, Antoinette
    Reese-Koc, Jane
    Maschan, Mikhail
    Dropulic, Boro
    Sekaly, Rafick-Pierre
    De Lima, Marcos
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [8] CAR T-Cell Therapy in Non-Hodgkin Lymphoma Patients
    Copelan, Edward A.
    ONCOLOGY-NEW YORK, 2019, 33 (02): : 73 - +
  • [9] CAR-T therapy approved for non-Hodgkin's lymphoma
    不详
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (12) : 2752 - 2752
  • [10] Regulatory T cells in non-Hodgkin lymphoma patients
    Gergely, L.
    Zombori, L.
    Ress, Zs.
    Varoczy, L.
    Remenyi, Gy.
    Barath, S.
    Illes, A.
    BLOOD REVIEWS, 2007, 21 : S127 - S127
12345